Study to determine safety and effects of ergocalciferol on erythropoietin dosing in hemodialysis patients
An interventional study is being conducted by Dialysis Clinic, Inc. to determine the safety and effect of supplementation with ergocalciferol on erythropoietin dosing in hemodialysis patients.
A new study has found that treatment with anaemia drug doesnt benefit kidney disease patients who are on dialysis.